ÃâÒßѧÊÔÌâ
#ONad0T; Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
VM1`:1Z:$ 1. Fas(CD95)/FasL
&]'{N69@d? 2. common chain of cytokine receptor
/Jjub3>Q 3 . TCR/CD3 complex
J.r^"K\ 4. negaive selection of thymocytes
gua +-##) 5. artificial active immune
s^@?+<4: 6. anti-idiotypic
G>/Gw90E 7. IgSF
Nm.H
8. Integrin
zF9SZ#{a 9. chemokine
,F,\bp } 10. B7/CD28
6 K+DgNK ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
sO,%Ok1 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
OO Hw-MW 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
yM*-em 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
ADTx _tE 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
J|9kWjOf+i
G234UjN% 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
Ho}"8YEXNV µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
yMU>vr Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
Xu4C*]A> 1. B7/CD28
TY(B]Q_o 2. Th1 subset
r\OunGUP 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
t<)C
bple\ 4. antibody affinity maturation
otA59 ;Z 5. AP-1
F;4*,Ap 6. single chain variable fragment£¨ScFv£©
>MuI-^3 7. NK cell receptor
8T7ex(w 8. Zinkernagel-Doherty phenomenon
?ztI8I/ 9. Ig fold
C 2f=9n/ 10. CD40/CD40L
S}O>@% ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
Fgx{ s%&- 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
:y/1Jf'2f 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
-B`Nkc
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
1JRM@ !x Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
BBV"nm_(/ 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
7L%JCH#F 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
<EhOIN7@*D 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
^tMb"WO Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
!"v[\||1 £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
'|I8byiK Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
yQT
cO^E 1.Co-stimulators (or co-stimulating molecules)
/C[Q? 2.NK-kB
*^ZJ&. 3.Immunoglobulin superfamily
"QKCZ8_C 4.antigen-presenting cell (APC)
$U_M|
Xa 5.death domain
Q9yIQ{>H[ 6.CCR and CXCR
syJLcK+e 7.Lectin (or mitogen)
V-{3)6I$hG 8.Clusters of differentiation, CD)
-wh?9?W 9.B7 family
V< Ib#rd' 10.Cytotoxic T lymphocyte, CTL)
':>u* 11.IL-15 and IL-15 receptor (IL-15R)
@A5'vf|2;. 12.MHC restriction
|p .o ^ 13.Affinity-chromatography
rD\)ndPv 14.Cyctosprin A, CsA
%(uYYr
6 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
)+ V)]dS@% ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
]\C wa9 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
( <e q[( 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
VMee"'08 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
C09rgEB\B Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
gTS}'w{ ÃâÒßѧרҵ£º
|AQU\BUj 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
lR
>p Ïû»¯ÄÚ¿Æ£º
QZm7
Q4 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
iYf)FPET ѪҺ²¡Ñ§×¨Òµ£º
9/`3=r@ 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
=.qX u+ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
n)j0
h- (רҵ»ù´¡: ÃâÒßѧ)
}BUm}.-{u, Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
+MqJJuWB 1. ADCC(antibody dependent cell-mediated cytotoxicity)
Ne)3@? 2. »·æß¾úËØ(cyclosporin)
PfsUe,* 3. KIR(killer cell inhibitory receptor)
jLA)Y
[h 4. HLDA(human leucocyte differentiation antigen)
o-o -'0l 5. Interleukin 18(IL-18)
.Y0O. 6. ÕûºÏËØ(integrin)
4T TrHs 7. Fas/FasL
T/.U Mw 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
0@um 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
Qo!F?i/ n 10. Th1/Th2
Na4O( d` 11. »ùÒòÒßÃç(DNAÒßÃç)
'1rGsfp6In 12. chemokines and chemokine receptor
MGf *+!y, 13. ÃâÒßÄÍÊÜ
Ai"MJ6) 14. ¹²´Ì¼¤·Ö×Ó
+\*b?x 15. ËÀÍö½á¹¹Óò(death domain)
/1p5KVTKv ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
$@vB<(sk 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
kl[(!"p 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
m[%':^vSr £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
o:&8H>(hn] £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
;B;@MD,B £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
d&AO4^ £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
XdmpfUR,13 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
s)fahc(@E Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
*~YdL7f)J ÎÊ´ðÌâ(ÿÌâ25·Ö)
t%G.i@{pkp 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
,(-V<>/*.| 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
z]SEPYq: 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
:iLRCK3C 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£